Top stories
Dr. Jonathan Licht MD
USINFO | 2013-11-28 15:21
Medical Oncologist
Contact Information
675 N Saint Clair St
Chicago, IL 60611
Phone: (866) 587-4322
Specialty & Clinical Interests
Medical Oncologist: General Oncology
Hospital Affiliation
Northwestern Memorial Hospital
Ranked #14 in Cancer
Mount Sinai Hospital
High performing in Cancer
Education & Medical Training
Beth Israel Deaconess Medical Center
Residency, Internal Medicine, 1982 - 1985
Dana - Farber Cancer Institute
Fellowship, Medical Oncology, 1985 - 1988
Columbia University College of Physicians and Surgeons
Class of 1982
Certifications & Licensure
American Board of Internal Medicine
Certified 28 years in Internal Medicine
American Board of Internal Medicine
Certified 26 years in Medical Oncology
IL State Medical License
Active through 2014
NY State Medical License
Active through 2014
Awards, Honors & Recognition
ASCI Member, The American Society for Clinical Investigation
2007
ASCI Member, The American Society for Clinical Investigation
2001
Publications & Presentations
Spry1 and Spry2 are necessary for eyelid closure.
Kuracha, M. R.,Siefker, E.,Licht, J. D.,Govindarajan, V.
Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors.
Mehrotra, S.,Sharma, B.,Joshi, S.,Kroczynska, B.,Majchrzak, B.,Stein, B. L.,McMahon, B.,Altman, J. K.,Licht, J. D.,Baker, D. P.,Eklund, E. A.,Wickrema, A.,Verma, A.,Fish, E. N.,Platanias, L. C.
Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.
Oyer, J. A.,Huang, X.,Zheng, Y.,Shim, J.,Ezponda, T.,Carpenter, Z.,Allegretta, M.,Okot-Kotber, C. I.,Patel, J. P.,Melnick, A.,Levine, R. L.,Ferrando, A.,Mackerell, A. D.,Kelleher, N. L.,Licht, J. D.,Popovic, R.
Contact Information
675 N Saint Clair St
Chicago, IL 60611
Phone: (866) 587-4322
Specialty & Clinical Interests
Medical Oncologist: General Oncology
Hospital Affiliation
Northwestern Memorial Hospital
Ranked #14 in Cancer
Mount Sinai Hospital
High performing in Cancer
Education & Medical Training
Beth Israel Deaconess Medical Center
Residency, Internal Medicine, 1982 - 1985
Dana - Farber Cancer Institute
Fellowship, Medical Oncology, 1985 - 1988
Columbia University College of Physicians and Surgeons
Class of 1982
Certifications & Licensure
American Board of Internal Medicine
Certified 28 years in Internal Medicine
American Board of Internal Medicine
Certified 26 years in Medical Oncology
IL State Medical License
Active through 2014
NY State Medical License
Active through 2014
Awards, Honors & Recognition
ASCI Member, The American Society for Clinical Investigation
2007
ASCI Member, The American Society for Clinical Investigation
2001
Publications & Presentations
Spry1 and Spry2 are necessary for eyelid closure.
Kuracha, M. R.,Siefker, E.,Licht, J. D.,Govindarajan, V.
Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors.
Mehrotra, S.,Sharma, B.,Joshi, S.,Kroczynska, B.,Majchrzak, B.,Stein, B. L.,McMahon, B.,Altman, J. K.,Licht, J. D.,Baker, D. P.,Eklund, E. A.,Wickrema, A.,Verma, A.,Fish, E. N.,Platanias, L. C.
Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.
Oyer, J. A.,Huang, X.,Zheng, Y.,Shim, J.,Ezponda, T.,Carpenter, Z.,Allegretta, M.,Okot-Kotber, C. I.,Patel, J. P.,Melnick, A.,Levine, R. L.,Ferrando, A.,Mackerell, A. D.,Kelleher, N. L.,Licht, J. D.,Popovic, R.
